tDCS + Speech Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether combining speech therapy with transcranial direct current stimulation (tDCS) can aid individuals with chronic aphasia, a language disorder often caused by a stroke. Participants will receive either real or sham tDCS alongside their therapy to determine if the real stimulation enhances language recovery. Individuals who experienced a left hemisphere stroke over six months ago and have been diagnosed with aphasia may qualify, provided they have not recently undergone other speech therapy and can attend 16 sessions over 8 weeks. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve language recovery options for future patients.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a history of seizures or have changed seizure medication in the past 12 months, you may be excluded from participating.
What prior data suggests that transcranial direct current stimulation (tDCS) is safe for use in aphasia therapy?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated in human trials. Studies indicate that standard tDCS methods (up to 40 minutes, 4 milliamps) have not caused any serious side effects. This treatment is noninvasive and not painful, making it a promising option for helping people with aphasia recover language skills after a stroke.
Speech-language therapy (SLT) is a common and safe method for improving speech and language skills in people with aphasia. When combined with tDCS, this therapy might offer even greater benefits without major safety concerns.
Overall, research supports the safety of both tDCS and SLT, providing a strong basis for their use in clinical settings.12345Why are researchers excited about this trial?
Researchers are excited about using transcranial direct current stimulation (tDCS) combined with speech therapy for aphasia because it offers a novel approach compared to traditional speech-language therapy alone. Unlike standard treatments that primarily focus on rehabilitating language skills through practice and exercises, tDCS involves applying a mild electrical current to specific brain areas, potentially enhancing the brain's ability to repair and reorganize itself. This technique could speed up recovery and improve outcomes by stimulating brain regions involved in speech and language. Additionally, the use of a sham comparator allows researchers to assess the true efficacy of tDCS, helping to distinguish its benefits from the placebo effect.
What evidence suggests that this trial's treatments could be effective for aphasia?
This trial will compare the effects of anodal transcranial direct current stimulation (A-tDCS) combined with speech-language therapy (SLT) to a sham version of tDCS combined with SLT. Studies have shown that using a gentle electrical treatment like A-tDCS with SLT can aid people with language problems after a stroke. Research suggests this combination might enhance their ability to speak and repeat words. Some studies indicate that the electrical treatment in tDCS can enhance traditional language therapy. However, other studies have mixed results, with some showing no significant difference when comparing A-tDCS to a sham version. Overall, while the results are promising, they vary, so more research is needed to confirm its effectiveness.13567
Who Is on the Research Team?
E. Susan Duncan, PhD, CCC-SLP
Principal Investigator
City University of New York
Are You a Good Fit for This Trial?
This trial is for right-handed, English-speaking adults with a high school education who had a single-event left hemisphere stroke over 6 months ago and have chronic aphasia. They must not be receiving other speech therapies during the study or have any conditions that would interfere with MRI scans, such as metal implants or pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Treatment Assessment
Participants complete behavioral assessments and brain scans before therapy
Treatment
Participants receive tDCS and aphasia therapy for 8 weeks
Post-Treatment Assessment
Behavioral assessments and brain scans are conducted immediately after therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Anodal transcranial direct current stimulation
- Sham transcranial direct current stimulation
- Speech-Language Therapy (SLT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Louisiana State University and A&M College
Lead Sponsor
City University of New York
Lead Sponsor